Approval · Notice of Compliance 2572 · 2001
VENTODISK: Notice of Compliance 2572
Issued August 22, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2572
- Date
- August 22, 2001
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer name
- Therapeutic class
- Bronchodilator (beta2-adrenergic stimulant)
Products in this notice
Medicinal ingredients
- SALBUTAMOL SULFATE 200 MCG per BLD
- SALBUTAMOL SULFATE 400 MCG per BLD